XML 67 R54.htm IDEA: XBRL DOCUMENT v3.20.2
Investment Information - Net realized gains and losses (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Available for sale securities:        
Available for sale securities, gross gains on investment sales $ 232,153 $ 75,090 $ 410,353 $ 118,455
Available for sale securities, gross losses on investment sales (49,824) (15,281) (81,792) (46,937)
Equity securities, at fair value:        
Net realized gains (losses) on sales during the period (18,250) (6,644) (18,789) 4,286
Net unrealized gains (losses) on equity securities still held at reporting date 145,686 22,632 (29,880) 59,768
Allowance for credit losses:        
Allowance for credit losses - investment related (1,000)   (10,349)  
Allowance for credit losses - underwriting related (5,834) 0 (9,104) 0
Net impairment losses 0 (49) (533) (1,358)
Derivative instruments [1] (836) 63,966 126,353 99,837
Other (6,515) (1,628) (8,612) (10,038)
Net realized gains (losses) 556,588 120,757 189,628 261,013
Fixed maturities        
Available for sale securities:        
Change in fair value of assets and liabilities accounted for using the fair value option 68,181 11,429 (59,485) 42,577
Allowance for credit losses:        
Allowance for credit losses - investment related 3,225 0 (6,095) 0
Other investments        
Available for sale securities:        
Change in fair value of assets and liabilities accounted for using the fair value option 178,570 (33,780) (129,230) (15,585)
Equity securities        
Available for sale securities:        
Change in fair value of assets and liabilities accounted for using the fair value option 6,664 6,414 1,755 10,680
Short-term investments        
Available for sale securities:        
Change in fair value of assets and liabilities accounted for using the fair value option $ 3,368 $ (1,392) $ (5,313) $ (672)
[1]
See note 9 for information on the Company’s derivative instruments.